These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 6460865

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. A 4-quadrant comparative study of periodontal treatment using tetracycline-containing drug delivery fibers and scaling.
    Heijl L, Dahlen G, Sundin Y, Wenander A, Goodson JM.
    J Clin Periodontol; 1991 Feb; 18(2):111-6. PubMed ID: 2005224
    [Abstract] [Full Text] [Related]

  • 25. Nuclear medicine. An indicator of "active" alveolar bone loss in beagle dogs treated with nonsteroidal anti-inflammatory drug.
    Jeffcoat MK, Williams RC, Kaplan ML, Goldhaber P.
    J Periodontol; 1985 Nov; 56(11 Suppl):8-12. PubMed ID: 3908642
    [Abstract] [Full Text] [Related]

  • 26. Antibacterial susceptibility of plaque bacteria.
    Newman MG, Hulem C, Colgate J, Anselmo C.
    J Dent Res; 1979 Jul; 58(7):1722-32. PubMed ID: 286720
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Effect of modified Widman flap surgery and systemic tetracycline on the subgingival microbiota of periodontal lesions.
    Haffajee AD, Dzink JL, Socransky SS.
    J Clin Periodontol; 1988 Apr; 15(4):255-62. PubMed ID: 3164334
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Enhanced repair and regeneration of periodontal lesions in tetracycline-treated patients. Case reports.
    Moskow BS, Tannenbaum P.
    J Periodontol; 1991 May; 62(5):341-50. PubMed ID: 1649289
    [Abstract] [Full Text] [Related]

  • 32. Tetracycline: levels of achievable in gingival crevice fluid and in vitro effect on subgingival organisms. Part II. Susceptibilities of periodontal bacteria.
    Walker CB, Gordon JM, McQuilkin SJ, Niebloom TA, Socransky SS.
    J Periodontol; 1981 Oct; 52(10):613-6. PubMed ID: 7028940
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Semiconductor probe measurements in beagle dogs with periodontal disease.
    Kaplan ML, Jeffcoat MK, Goldhaber P.
    J Dent Res; 1978 Feb; 57(2):340-4. PubMed ID: 277532
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Response to periodontal therapy in patients with high or low levels of P. gingivalis, P. intermedia, P. nigrescens and B. forsythus.
    Haffajee AD, Socransky SS, Dibart S, Kent RL.
    J Clin Periodontol; 1996 Apr; 23(4):336-45. PubMed ID: 8739165
    [Abstract] [Full Text] [Related]

  • 38. [Antimicrobial approaches to periodontal therapy].
    Vitaya CT.
    J Dent Assoc Thai; 1990 Apr; 40(2):83-91. PubMed ID: 2074322
    [Abstract] [Full Text] [Related]

  • 39. Tissue concentration and localization of tetracycline following site-specific tetracycline fiber therapy.
    Ciancio SG, Cobb CM, Leung M.
    J Periodontol; 1992 Oct; 63(10):849-53. PubMed ID: 1403593
    [Abstract] [Full Text] [Related]

  • 40. The acquisition of antibiotic resistance in the periodontal microflora.
    Walker CB.
    Periodontol 2000; 1996 Feb; 10():79-88. PubMed ID: 9567938
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.